Jieun Lee

992 total citations
61 papers, 626 citations indexed

About

Jieun Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jieun Lee has authored 61 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 20 papers in Cancer Research. Recurrent topics in Jieun Lee's work include Cancer Genomics and Diagnostics (9 papers), Advanced Breast Cancer Therapies (8 papers) and Breast Cancer Treatment Studies (7 papers). Jieun Lee is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Advanced Breast Cancer Therapies (8 papers) and Breast Cancer Treatment Studies (7 papers). Jieun Lee collaborates with scholars based in South Korea, United States and Japan. Jieun Lee's co-authors include Iván J. Ramírez, Myung Ah Lee, Yong‐Hee Kim, Sung‐Il Cho, Jaehyun Kim, Shayan Fakhraei Lahiji, Jun‐Beom Park, Youngkyung Ko, Ahwon Lee and In-Ho Kim and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Jieun Lee

51 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jieun Lee South Korea 15 204 203 168 99 57 61 626
Bertrand Pourroy France 17 294 1.4× 331 1.6× 78 0.5× 98 1.0× 50 0.9× 47 823
Kiran Vanaja United States 8 131 0.6× 239 1.2× 64 0.4× 114 1.2× 22 0.4× 12 531
Shuhao Zhang China 14 71 0.3× 230 1.1× 79 0.5× 57 0.6× 109 1.9× 53 640
Somayeh Vafaei Iran 16 241 1.2× 292 1.4× 100 0.6× 174 1.8× 43 0.8× 43 792
Maoming Xiong China 16 246 1.2× 331 1.6× 147 0.9× 213 2.2× 112 2.0× 47 874
Patricia Thompson United States 8 359 1.8× 363 1.8× 84 0.5× 85 0.9× 38 0.7× 21 850
Xiuwei Chen China 17 156 0.8× 465 2.3× 99 0.6× 277 2.8× 63 1.1× 43 950
Wentao Tang China 15 314 1.5× 227 1.1× 150 0.9× 146 1.5× 90 1.6× 44 706
Rui Wan China 15 405 2.0× 245 1.2× 250 1.5× 160 1.6× 59 1.0× 73 870
Tao Jia China 14 90 0.4× 408 2.0× 68 0.4× 131 1.3× 47 0.8× 60 716

Countries citing papers authored by Jieun Lee

Since Specialization
Citations

This map shows the geographic impact of Jieun Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieun Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieun Lee more than expected).

Fields of papers citing papers by Jieun Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieun Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieun Lee. The network helps show where Jieun Lee may publish in the future.

Co-authorship network of co-authors of Jieun Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jieun Lee. A scholar is included among the top collaborators of Jieun Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieun Lee. Jieun Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sohn, Joohyuk, Jae Ho Jeong, Kyung-Hun Lee, et al.. (2025). Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+ advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial.. Journal of Clinical Oncology. 43(16_suppl). 1016–1016.
3.
4.
5.
Lee, Miseon, Tae-Kyung Yoo, Byung Joo Chae, et al.. (2024). Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification. Scientific Reports. 14(1). 11278–11278. 3 indexed citations
6.
Lee, Dae‐Won, Kyung Hae Jung, Kyung-Hun Lee, et al.. (2023). Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial. European Journal of Cancer. 197. 113456–113456. 1 indexed citations
7.
Lee, Jieun. (2023). Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC). Journal of Clinical Medicine. 12(4). 1524–1524. 60 indexed citations
8.
Kang, Jun, et al.. (2023). Case 10: A 30-Year-Old Woman With Breast Mass and Family History of Cancer. Journal of Korean Medical Science. 38(18). e138–e138.
9.
10.
Lee, Jieun, Hyung Soon Park, Hye Sung Won, et al.. (2020). Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions. Cancer Research and Treatment. 53(2). 409–423. 19 indexed citations
11.
Yang, Ji Hyun, et al.. (2020). Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer. The Korean Journal of Internal Medicine. 36(1). 182–193. 2 indexed citations
12.
Lee, Jieun, et al.. (2019). Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer. Journal of Breast Cancer. 22(4). 562–562. 12 indexed citations
13.
Lee, Jieun, et al.. (2017). Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer. PLoS ONE. 12(2). e0171605–e0171605. 5 indexed citations
14.
Park, Jun‐Beom, et al.. (2016). Evaluation of the effects of a low dose of on stem cell morphology and proliferation. Journal of Korean Medicine. 37(2). 85–92. 2 indexed citations
15.
Lee, Jieun, Seong-Ho Jin, Youngkyung Ko, & Jun‐Beom Park. (2014). Evaluation of anatomical considerations in the posterior maxillae for sinus augmentation.. Europe PMC (PubMed Central). 2(11). 683–8. 12 indexed citations
16.
Cho, Sung‐Il, et al.. (2014). Protective effect of silymarin against cisplatin-induced ototoxicity. International Journal of Pediatric Otorhinolaryngology. 78(3). 474–478. 27 indexed citations
17.
18.
Goh, Sung‐Ho, Sang Jin Lee, Jung-Ah Hwang, et al.. (2013). Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathway. Oncotarget. 4(10). 1791–1803. 40 indexed citations
19.
Lee, Jieun, et al.. (2009). Expression of GLUT-1 and EGFR in Head and Neck Squamous Cell Carcinoma. Korean Journal of Otorhinolaryngology - Head and Neck Surgery. 52(10). 822–822. 1 indexed citations
20.
Lee, Jieun, et al.. (2004). Therapeutic Efficacy of Alendronate for Glucocorticoid Induced Metabolic Bone Disease in Children with Nephrotic Syndrome. 8(1). 33–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertrand Pourroy Breakdown of academic impact, for papers by Kiran Vanaja Breakdown of academic impact, for papers by Shuhao Zhang Breakdown of academic impact, for papers by Somayeh Vafaei Breakdown of academic impact, for papers by Maoming Xiong Breakdown of academic impact, for papers by Patricia Thompson Breakdown of academic impact, for papers by Xiuwei Chen Breakdown of academic impact, for papers by Wentao Tang Breakdown of academic impact, for papers by Rui Wan Breakdown of academic impact, for papers by Tao Jia
Rankless by CCL
2026